Búsqueda | Biblioteca Virtual en Salud

1.

Higher Dosing of Rifamycins Does Not Increase Activity against Mycobacterium tuberculosis in the Hollow-Fiber Infection Model.

Pieterman, E D; van den Berg, S; van der Meijden, A; Svensson, E M; Bax, H I; de Steenwinkel, J E M.

Antimicrob Agents Chemother ; 65(4)2021 03 18.

Artículo en Inglés | MEDLINE | ID: mdl-33558283

2.

Optimal treatment for intermediate- and high-risk, nonmuscle-invasive bladder cancer.

van der Meijden, A P M.

ScientificWorldJournal ; 6: 2611-6, 2006 Mar 09.

Artículo en Inglés | MEDLINE | ID: mdl-17619738

3.

Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.

van Velthoven, R; Petein, M; Oosterlinck, W J; Zandona, C; Zlotta, A; Van der Meijden, A P; Pasteels, J L; Roels, H; Schulman, C; Kiss, R.

Hum Pathol ; 26(1): 3-11, 1995 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-7821913

4.

Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.

van der Meijden, A P; DeBruyne, F M.

Urology ; 31(3 Suppl): 26-9, 1988 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-3126592

5.

BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer. First results of randomized prospective trial.

DeBruyne, F M; van der Meijden, A P; Geboers, A D; Franssen, M P; van Leeuwen, M J; Steerenberg, P A; de Jong, W H; Ruitenberg, J J.

Urology ; 31(3 Suppl): 20-5, 1988 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-3279698

6.

Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group.

van der Meijden, A P; Kurth, K H; Oosterlinck, W; Debruyne, F M.

Cancer Chemother Pharmacol ; 30 Suppl: S95-8, 1992.

Artículo en Inglés | MEDLINE | ID: mdl-1394828

7.

Intravesical Bacillus Calmette-Guérin treatment for superficial bladder cancer: results after 15 years of experience.

van der Meijden, A P; Steerenberg, P A; de Jong, W H; Debruyne, F M.

Anticancer Res ; 11(3): 1253-8, 1991.

Artículo en Inglés | MEDLINE | ID: mdl-1888156

8.

Management of carcinoma of the bladder.

Petrovich, Z; Baert, L; Boyd, S D; Brady, L W; D'Hallewin, M; Heilmann, H P; Jakse, G; Jones, P A; Van Der Meijden, A P; Oyen, R H; Van Poppel, H; Rotman, M; Sauer, R; Shipley, W U; Skinner, E C.

Am J Clin Oncol ; 21(3): 217-22, 1998 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-9626784

9.

Non specific immunotherapy with B.C.G. in superficial bladder cancer: an overview.

Van der Meijden, A P.

In Vivo ; 5(6): 599-604, 1991.

Artículo en Inglés | MEDLINE | ID: mdl-1810445

10.

Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin.

De Boer, E C; De Jong, W H; Steerenberg, P A; Van der Meijden, A P; Aarden, L A; Debruyne, F M; Ruitenberg, E J.

In Vivo ; 5(6): 671-7, 1991.

Artículo en Inglés | MEDLINE | ID: mdl-1810454

11.

Deep intraspecific divergences in the medically relevant fat-tailed scorpions (Androctonus, Scorpiones).

Coelho, P; Sousa, P; Harris, D J; van der Meijden, A.

Acta Trop ; 134: 43-51, 2014 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-24524948

12.

Intravesical instillation therapy: alternative treatments.

Debruyne, F M; van der Meijden, A P; Witjes, J A.

Recent Results Cancer Res ; 126: 119-25, 1993.

Artículo en Inglés | MEDLINE | ID: mdl-8456182

13.

New treatment approaches for superficial and invasive bladder cancer.

Grossman, H B; Debruyne, F M; Akaza, H; Aso, Y; Kagawa, S; Kakehi, Y; van der Meijden, A P; Ratliff, T L.

Urol Oncol ; 4(4-5): 183-7, 1998.

Artículo en Inglés | MEDLINE | ID: mdl-21227224

14.

Bladder cancer.

van der Meijden, A P.

BMJ ; 317(7169): 1366-9, 1998 Nov 14.

Artículo en Inglés | MEDLINE | ID: mdl-9812938

15.

[Long-term application of the percutaneous, suprapubic bladder catheter]. / Langdurige toepassing van de percutane, suprapubische blaascatheter.

van der Meijden, A P; Janknegt, R A.

Ned Tijdschr Geneeskd ; 127(7): 288-90, 1983 Feb 12.

Artículo en Neerlandesa | MEDLINE | ID: mdl-6855968

16.

[Intranasal administration of luteinizing hormone-releasing hormone in the treatment of undescended testis]. / Intranasale toediening van luteinising hormone-releasing hormone voor de behandeling van de niet-ingedaalde testis.

van der Meijden, A P; Schreinemachers, L M; Janknegt, R A.

Ned Tijdschr Geneeskd ; 128(21): 992-6, 1984 May 26.

Artículo en Neerlandesa | MEDLINE | ID: mdl-6146098

17.

[Testis tumor, an insidious disease]. / Testistumor, een verraderlijke ziekte.

van der Meijden, A P; Hoekstra, J W; Janknegt, R A.

Ned Tijdschr Geneeskd ; 128(31): 1457-9, 1984 Aug 04.

Artículo en Neerlandesa | MEDLINE | ID: mdl-6483000

18.

Practical approaches to the prevention and treatment of adverse reactions to BCG.

van der Meijden, A P.

Eur Urol ; 27 Suppl 1: 23-8, 1995.

Artículo en Inglés | MEDLINE | ID: mdl-7750529

19.

Practical aspects of clinical trials on chemoprevention of prostate cancer.

van der Meijden, A P.

Eur Urol ; 35(5-6): 515-8, 1999.

Artículo en Inglés | MEDLINE | ID: mdl-10325517

20.

The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials.

Van Der Meijden, A; Sylvester, R; Collette, L; Bono, A; Ten Kate, F.

J Urol ; 164(5): 1533-7, 2000 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-11025698

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Higher Dosing of Rifamycins Does Not Increase Activity against Mycobacterium tuberculosis in the Hollow-Fiber Infection Model.

Optimal treatment for intermediate- and high-risk, nonmuscle-invasive bladder cancer.

Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.

Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.

BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer. First results of randomized prospective trial.

Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group.

Intravesical Bacillus Calmette-Guérin treatment for superficial bladder cancer: results after 15 years of experience.

Management of carcinoma of the bladder.

Non specific immunotherapy with B.C.G. in superficial bladder cancer: an overview.

Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin.

Deep intraspecific divergences in the medically relevant fat-tailed scorpions (Androctonus, Scorpiones).

Intravesical instillation therapy: alternative treatments.

New treatment approaches for superficial and invasive bladder cancer.

Bladder cancer.

[Long-term application of the percutaneous, suprapubic bladder catheter]. / Langdurige toepassing van de percutane, suprapubische blaascatheter.

[Intranasal administration of luteinizing hormone-releasing hormone in the treatment of undescended testis]. / Intranasale toediening van luteinising hormone-releasing hormone voor de behandeling van de niet-ingedaalde testis.

[Testis tumor, an insidious disease]. / Testistumor, een verraderlijke ziekte.

Practical approaches to the prevention and treatment of adverse reactions to BCG.

Practical aspects of clinical trials on chemoprevention of prostate cancer.

The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials.